Leptin antagonism led to several immunological changes in SLE mice, including an increase in the percentage of circulating CD4+ T cells, an increase in the CD4/CD8 ratio, and a decrease in circulating DN T cells. The gene discussed is CD8A; the disease is systemic lupus erythematosus.